Literature DB >> 16110285

Prediction of early and late recurrence in patients with breast carcinoma.

Hideya Takeuchi1, Kohichi Tsuji, Hiroaki Ueo.   

Abstract

BACKGROUND: The clinical course of patients with recurrent breast carcinoma varies greatly. Better characterization of an individual's clinical course for recurrent patients may aid in their clinical management. However, less attention has been paid to evaluating factors associated with the timing of recurrence in those patients. We investigated the clinicopathological indicators that determined the timing of recurrence by univariate and multivariate analysis.
METHODS: We retrospectively examined data on 1428 curatively treated Japanese patients who had been surgically treated for breast cancer between 1983 and 2002. From these, 244(17.1%)who had clearly died of recurrence were entered into this study.
RESULTS: By univariate analysis, tumor size, estrogen receptor(ER), and progesterone receptor(PgR)were significantly correlated with time to recurrence. Multivariate analysis indicated that the time between operation and recurrence was independently influenced by ER and PR.
CONCLUSIONS: Our research shows that ER and PgR are independent factors influencing the timing of recurrence of breast carcinoma after curative resection. The combined analysis of these independent factors facilitates prediction of the time to recurrence for each patient.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16110285     DOI: 10.2325/jbcs.12.161

Source DB:  PubMed          Journal:  Breast Cancer        ISSN: 1340-6868            Impact factor:   4.239


  6 in total

1.  The differences of clinicopathological factors for breast cancer in respect to time of recurrence and effect on recurrence-free survival.

Authors:  B B Oven Ustaalioglu; O Balvan; A Bilici; A Develi; M Aliustaoglu; F A Vardar; B Erkol
Journal:  Clin Transl Oncol       Date:  2015-06-17       Impact factor: 3.405

2.  Malignant pleural effusion in breast cancer 12 years after mastectomy that was successfully treated with endocrine therapy.

Authors:  Tsuyoshi Shinohara; Hiroyuki Yamada; Yoshiro Fujimori; Kiyofumi Yamagishi
Journal:  Am J Case Rep       Date:  2013-06-03

3.  Factors associated with the incidence of local recurrences of breast cancer in women who underwent conservative surgery.

Authors:  Juliana Rodrigues Tovar; Eliana Zandonade; Maria Helena Costa Amorim
Journal:  Int J Breast Cancer       Date:  2014-11-04

4.  Acute acalculous cholecystitis due to breast cancer metastasis to the cystic duct.

Authors:  Masakazu Hashimoto; Kei Koide; Michinori Arita; Koji Kawaguchi; Masakazu Tokunaga; Yoshihiro Mikuriya; Toshiyuki Iwamoto
Journal:  Surg Case Rep       Date:  2016-10-12

5.  Epsin Family Member 3 and Ribosome-Related Genes Are Associated with Late Metastasis in Estrogen Receptor-Positive Breast Cancer and Long-Term Survival in Non-Small Cell Lung Cancer Using a Genome-Wide Identification and Validation Strategy.

Authors:  Birte Hellwig; Katrin Madjar; Karolina Edlund; Rosemarie Marchan; Cristina Cadenas; Anne-Sophie Heimes; Katrin Almstedt; Antje Lebrecht; Isabel Sicking; Marco J Battista; Patrick Micke; Marcus Schmidt; Jan G Hengstler; Jörg Rahnenführer
Journal:  PLoS One       Date:  2016-12-07       Impact factor: 3.240

6.  Evaluation of circulating tumor cells as a prognostic biomarker for early recurrence in stage II-III breast cancer patients using CytoSorter® system: a retrospective study.

Authors:  Lidan Jin; Wan-Hung Fan; Yi Luan; Meiqiong Wu; Wenhe Zhao
Journal:  PeerJ       Date:  2021-04-29       Impact factor: 2.984

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.